サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1348656

臨床意思決定支援システムの世界市場：コンポーネント別、製品別、タイプ別、モデル別、提供形態別、用途別、インタラクティビティ別、医療環境別-2028年までの予測

Clinical Decision Support Systems Market by Component, Delivery, Product, Application, Interactivity - Global Forecasts to 2028
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 279 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.46円
臨床意思決定支援システムの世界市場：コンポーネント別、製品別、タイプ別、モデル別、提供形態別、用途別、インタラクティビティ別、医療環境別-2028年までの予測
出版日: 2023年09月12日
発行: MarketsandMarkets
ページ情報: 英文 279 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の臨床意思決定支援システム（CDSS）の市場規模は、2023年の17億米ドルから2028年には25億米ドルに達すると予測され、予測期間中のCAGRは7.5%と見込まれています。

同市場の成長は主に、HITソリューションの採用を促進するための政府規制やイニシアチブの実施、CDSS対応EHRの採用拡大、利害関係者間の連携やパートナーシップの拡大、投薬ミスの発生率の上昇、mヘルスやビッグデータツールの開発によってもたらされます。

しかし、CDSS導入のための投資要件が高いこと、相互運用性が不十分であること、データセキュリティへの懸念が高まっていることなどが、予測期間中の同市場の成長を抑制する要因になると予想されます。

コンポーネント別に見ると、2022年は、サービス分野が最大のシェアを占めました。複雑なソフトウェアのイントロダクション、統合、ソフトウェアの相互運用性により、大規模なトレーニングやアップグレードが必要となるため、サービスに対する需要は今後数年間で急速に拡大する見込みです。

提供形態別に見ると、臨床意思決定支援システム市場はオンプレミス型とクラウド型に分かれます。2023年には、オンプレミス型CDSSセグメントが臨床意思決定支援システム市場で最大のシェアを占めると予測されています。このモデルで発生する資本費用や運用コストの低さ、拡張性、柔軟性、低コストといった要因が、市場成長の原動力となっています。

用途別では、臨床意思決定支援システム市場は従来型CDSSと先進型CDSSに分けられます。従来型CDSSセグメントが2022年の市場で最大のシェアを占めています。医療機関がポイントオブケアで介護者にガイダンスやリマインダーを提供するために従来型の意思決定支援システムを採用していることなどが市場成長を促進しています。

製品別では、臨床意思決定支援システム市場は統合型CDSSとスタンドアロン型CDSSに分けられ、統合型CDSSセグメントが2022年の市場で最大のシェアを占めています。このセグメントの大きなシェアは、ヘルスケアプロバイダによる投薬ミスの減少、および健康アウトカムとケアの質を向上させるための統合CDSSの利用増加によるものと考えられます。

当レポートでは、世界の臨床意思決定支援システム市場について調査し、コンポーネント別、製品別、タイプ別、モデル別、提供形態別、用途別、インタラクティビティ別、医療環境別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
  • 顧客のビジネスに影響を与える動向/混乱
  • バリューチェーン分析
  • ケーススタディ分析
  • エコシステム分析
  • 技術分析
  • 関税と規制の分析
  • ポーターのファイブフォース分析
  • 業界の動向
  • ビジネスモデル
  • 価格分析
  • 特許分析
  • 主要な会議とイベント
  • 貿易分析
  • 主要な利害関係者と購入基準

第6章 臨床意思決定支援システム市場、コンポーネント別

  • イントロダクション
  • サービス
  • ソフトウェア
  • ハードウェア

第7章 臨床意思決定支援システム市場、製品別

  • イントロダクション
  • 統合型CDSS
  • スタンドアロン型CDSS

第8章 臨床意思決定支援システム市場、タイプ別

  • イントロダクション
  • 治療用
  • 診断用

第9章 臨床意思決定支援システム市場、モデル別

  • イントロダクション
  • 知識ベースのCDSS
  • 非知識ベースのCDSS

第10章 臨床意思決定支援システム市場、提供形態別

  • イントロダクション
  • オンプレミス
  • クラウドベース

第11章 臨床意思決定支援システム市場、用途別

  • イントロダクション
  • 従来型
  • 高度型

第12章 臨床意思決定支援システム市場、インタラクティビティ別

  • イントロダクション
  • アクティブ
  • パッシブ

第13章 臨床意思決定支援システム市場、医療環境別

  • イントロダクション
  • 入院施設
  • 外来診療

第14章 臨床意思決定支援システム市場、地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第15章 競合情勢

  • 概要
  • 主要参入企業が採用した戦略
  • 主要市場参入企業の収益シェア分析
  • 市場シェア分析
  • 企業評価マトリックス
  • スタートアップ/中小企業向けの企業評価マトリクス
  • 競合状況・動向

第16章 企業プロファイル

  • 主要参入企業
    • EPIC SYSTEMS CORPORATION
    • WOLTERS KLUWER N.V.
    • ORACLE
    • MERATIVE
    • VERADIGM LLC
    • CHANGE HEALTHCARE（PART OF OPTUM）
    • ATHENAHEALTH
    • ELSEVIER（DIVISION OF RELX GROUP）
    • ZYNX HEALTH INCORPORATED
    • KONINKLIJKE PHILIPS N.V.
    • MEDICAL INFORMATION TECHNOLOGY, INC.
    • NEXTGEN HEALTHCARE, INC.
    • CUREMD HEALTHCARE
    • SIEMENS HEALTHINEERS
    • EBSCO INFORMATION SERVICES
    • GE HEALTHCARE
    • ECLINICALWORKS, LLC
    • THE MEDICAL ALGORITHMS COMPANY LIMITED
    • HERA-MI
    • RAMPMEDICAL
  • その他の企業
    • CARECLOUD, INC.
    • VISUALDX
    • STANSON HEALTH（PART OF PREMIER, INC.）
    • FIRST DATABANK, INC.
    • STRATA DECISION TECHNOLOGY
    • ALCIDION

第17章 付録

目次
Product Code: HIT 2237

The global clinical decision support systems (CDSS) market is projected to reach USD 2.5 billion by 2028 from USD 1.7 billion in 2023, at a CAGR of 7.5% during the forecast period. The growth of this market is primarily driven by the implementation of government regulations and initiatives to promote the adoption of HIT solutions, increasing adoption of CDSS-enabled EHRs, growing collaborations and partnerships between stakeholders, rising incidence of medication errors, and the development mHealth and big data tools.

However, high investment requirements for the implementation of CDSS and inadequate interoperability coupled with rising data security concerns are factors expected to restrain the growth of this market during the forecast period.

"Software segment is expected to grow at the highest rate from 2023 to 2028"

By component, the clinical decision support systems market is divided into services, software, and hardware. The services segment accounted for the largest share of this market in 2022 The demand for services is expected to grow rapidly in the coming years due to the introduction of complex software, integration, and software interoperability, which requires extensive training and upgrades.

"The On-premise CDSS segment is estimated to account for the largest share of the Clinical decision support systems market in 2023"

By delivery mode, the clinical decision support systems market is divided into on-premise and cloud-based modes. In 2023, the on-premise CDSS segment is projected to hold the largest share of the clinical decision support systems market.Factors such as lower capital expenses and operational costs incurred in this model, together with its scalability, flexibility, and low-cost are driving the market growth.

"In 2022, conventional CDSS segment accounted for the largest share of the global Clinical decision support systems market, by application"

By application, the clinical decision support systems market is divided into conventional CDSS and advanced CDSS. The conventional CDSS segment accounted for the largest share of the market in 2022. Factors such as healthcare organizations are adopting conventional decision support systems to provide guidance and reminders to caregivers at the point-of-care are driving the market growth.

"In 2022, Integrated CDSS segment accounted for the largest share of the global Clinical decision support systems market"

By product, the clinical decision support systems market is divided into integrated CDSS and standalone CDSS. The integrated CDSS segment accounted for the largest share of the market in 2022. The large share of this segment can be attributed to the reduce medication errors by healthcare providers and increased usage of integrated CDSS to improve the health outcomes and quality of care .

"The therapeutic CDSS segment is expected to grow with the highest CAGR from 2023 to 2028"

By type, the clinical decision support systems market is divided into therapeutic CDSS and diagnostic CDSS. The therapeutic CDSS segment dominated this market in 2022 This highest growth rate of this segment can be attributed to factors such as as therapeutic CDSS is equipped with a high computational capacity and a wealth of medical knowledge, making it plausible for clinicians to make informed therapeutic decisions (based on patient-specific medical facts).

"Knowledge-based CDSS segment accounted for the largest share of the global Clinical decision support systems market, by model"

The clinical decision support systems market is categorized into two main models: knowledge-based CDSS and non-knowledge-based CDSS. In 2022, the knowledge-based CDSS segment held the largest market share. This particular segment is projected to experience substantial growth throughout the forecast period. This growth can be attributed to the escalating need for personalized and evidence-based medicine, alongside the growing prevalence of chronic ailments.

"The Active CDSS segment is expected to grow with the highest CAGR during the forecast period"

The clinical decision support systems market can be categorized based on interactivity level into active CDSS and passive CDSS. In 2022, the active CDSS segment dominated the market share, and it is anticipated to exhibit the most rapid growth rate during the forecast period. Strong governmental efforts aimed at fostering clinical IT solutions, including EHR, CDSS, and CPOE, along with the increasing imperative to control healthcare expenditures, contribute to the advancement of this specific market segment.

"Inpatient settings accounted for the largest share of the global Clinical decision support systems market in 2022"

In terms of setting, the clinical decision support systems market is categorized into inpatient and ambulatory care settings. In 2022, the inpatient settings dominated the CDSS market share. This dominance can be attributed to the substantial accumulation and analysis of extensive patient data within inpatient settings, consequently driving the heightened uptake of integrated healthcare IT modules.

"North America to dominate the Clinical decision support systems market in 2023"

North America accounted for the largest share of the global clinical decision support systems market in 2022.

Elements including the existence of major industry participants, regulatory directives that support CDSS adoption, and the rise in medication errors in the US and Canada contribute to these trends.

Forecasts indicate that the Asia Pacific region will witness the most significant compound annual growth rate (CAGR) throughout the projected timeframe. This is due to factors such as the escalating prevalence of chronic illnesses and the growing attention of diverse market stakeholders toward emerging Asian nations. These factors are anticipated to propel the expansion of the clinical decision support systems market in the Asia Pacific region.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (45%), Tier 2 (35%), and Tier 3 (20%)
  • By Designation: C-level (26%), Director-level (17%), and Others (57%)
  • By Region: North America (40%), Europe (20%), Asia Pacific (30%), and Latin America (6%), MEA(4%)

Prominent players operating in the clinical decision support systems market are Wolters Kluwer N.V. (Netherlands), Oracle (US), Merative (US), Change Healthcare (US), Veradigm Inc. (US), athenahealth (US), Epic Systems Corporation (US), Elsevier B.V. (Netherlands), Zynx Health (US), Koninklijke Philips N.V. (Netherlands), Medical Information Technology, Inc. (US), NextGen Healthcare, Inc. (US), CureMD Healthcare (US), Siemens Healthineers (Germany), EBSCO Information Services (US), GE HealthCare (US), eClinicalWorks (US), The Medical Algorithms Company (UK), RAMPmedical (Germany), Hera-MI (France), CareCloud, Inc. (US), VisualDx (US), Premier, Inc. (US), First Databank, Inc. (US), and Strata Decision Technology (US).

Research Coverage

  • The report studies the Clinical decision support systems market based on component, delivery mode, product, model, interactivity level, application, setting, type, and region
  • The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
  • The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
  • The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total Clinical decision support systems market
  • The report forecasts the revenue of market segments with respect to four major regions

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Analysis of key drivers (implementation of government regulations & initiatives to promote the adoption of HCIT solutions, increasing adoption of cdss-enabled ehrs,growing collaborations & partnerships between stakeholders, growing incidence of medication errors ,development of big data and mhealth tools), restraints (data security concerns related to cloud-based cdss, inadequate interoperability), opportunities (growth potential of emerging markets, social media integration and rising technological advancements), challenges (requirement of high investments for the implementation of CDSS infrastructure ,shortage of skilled IT professionals in the healthcare industry).
  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global Clinical decision support systems Market. The report analyzes this market by component, delivery mode, product, model, interactivity level, application, setting, type.
  • Service Enhancement/Innovation: Detailed insights on upcoming trends in the global Clinical decision support systems
  • Market Development: Comprehensive information on the lucrative emerging markets by component, delivery mode, product, model, interactivity level, application, setting, type.
  • Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global Clinical decision support systems Market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Clinical decision support systems Market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 CDSS MARKET SEGMENTATION
    • 1.3.2 REGIONS COVERED
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 MAJOR STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES
  • 1.7 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 5 HYPOTHESIS BUILDING
  • 2.3 MARKET SIZE ESTIMATION METHODOLOGY
    • 2.3.1 APPROACH 1: REVENUE SHARE ANALYSIS
    • FIGURE 6 RESEARCH METHODOLOGY: MARKET ESTIMATION
    • 2.3.2 APPROACH 2: DEMAND-SIDE ANALYSIS
    • FIGURE 7 APPROACH 2: DEMAND SIDE ANALYSIS
    • 2.3.3 APPROACH 3: BOTTOM-UP AND SEGMENTAL EXTRAPOLATION
    • FIGURE 8 APPROACH 3: BOTTOM-UP AND SEGMENTAL EXTRAPOLATION
    • FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • FIGURE 10 CLINICAL DECISION SUPPORT SYSTEMS MARKET: CAGR PROJECTION ANALYSIS
  • 2.4 MARKET DATA ESTIMATION AND TRIANGULATION
    • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT ANALYSIS
  • 2.7 LIMITATIONS
    • 2.7.1 SCOPE-RELATED LIMITATIONS
    • 2.7.2 METHODOLOGY-RELATED LIMITATIONS
  • 2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2023 VS. 2028 (USD MILLION)
    • FIGURE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 17 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 18 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2023 VS. 2028 (USD MILLION)
    • FIGURE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2023 VS. 2028 (USD MILLION)
    • FIGURE 20 GEOGRAPHICAL SNAPSHOT OF CLINICAL DECISION SUPPORT SYSTEMS MARKET

4 PREMIUM INSIGHTS

  • 4.1 CLINICAL DECISION SUPPORT SYSTEMS MARKET OVERVIEW
    • FIGURE 21 INCREASING GOVERNMENT REGULATIONS FOR IMPLEMENTATION OF HCIT SOLUTIONS TO DRIVE MARKET
  • 4.2 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT AND COUNTRY
    • FIGURE 22 INTEGRATED CDSS SEGMENT DOMINATED US MARKET IN 2022
  • 4.3 CLINICAL DECISION SUPPORT SYSTEMS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
    • FIGURE 23 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • 4.4 CLINICAL DECISION SUPPORT SYSTEMS MARKET: REGIONAL MIX
    • FIGURE 24 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • 4.5 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DEVELOPED VS. EMERGING ECONOMIES
    • FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 26 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing government regulations for implementation of HCIT solutions
      • 5.2.1.2 Growing adoption of CDSS-enabled EHRs
      • 5.2.1.3 Rising incidence of medication errors
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Data security concerns in cloud-based CDSS
      • 5.2.2.2 Inadequate interoperability for patient management solutions
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Development of big data and mHealth tools
      • 5.2.3.2 High growth potential of emerging economies
      • 5.2.3.3 Rising technological advancements
    • 5.2.4 CHALLENGES
      • 5.2.4.1 High capital investments for CDSS infrastructure
      • 5.2.4.2 Shortage of skilled IT professionals
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 27 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR CLINICAL DECISION SUPPORT SYSTEMS MARKET
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 28 CLINICAL DECISION SUPPORT SYSTEMS MARKET: VALUE CHAIN ANALYSIS
  • 5.5 CASE STUDY ANALYSIS
    • 5.5.1 IMPROVING PATIENT OUTCOMES
    • TABLE 2 CASE 1: RISING FOCUS ON IMPROVING PATIENT SAFETY
    • 5.5.2 KNOWLEDGE ANALYZER DELIVERS ADVANCED CLINICAL EXPERIENCE
    • TABLE 3 CASE 2: RISING NEED TO STREAMLINE PATIENT OUTCOMES
    • 5.5.3 ENHANCING PHYSICIAN EFFICIENCY
    • TABLE 4 CASE 3: RISING NEED TO IMPROVE RESPONSE TIME AND PHYSICIAN EFFICIENCY IN HEALTHCARE FACILITIES
    • 5.5.4 INCREASING EFFICIENCY AND HEALTHCARE OUTCOMES WITH AI
    • TABLE 5 CASE 4: RISING FOCUS ON ENHANCING EFFICIENCY AND VALUE-BASED CARE WITH AI-POWERED CDSS
  • 5.6 ECOSYSTEM ANALYSIS
    • FIGURE 29 CLINICAL DECISION SUPPORT SYSTEM MARKET: ECOSYSTEM ANALYSIS
  • 5.7 TECHNOLOGY ANALYSIS
    • TABLE 6 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
  • 5.8 TARIFF AND REGULATORY ANALYSIS
    • 5.8.1 TARIFF FOR CDSS HARDWARE
    • 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 10 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.8.3 NORTH AMERICA
      • 5.8.3.1 Federal Food, Drug, and Cosmetic Act (FD&C Act)
      • 5.8.3.2 Health Insurance Portability and Accountability Act (HIPAA)
      • 5.8.3.3 Affordable Care Act, 2010
      • 5.8.3.4 Health Information Technology for Economic and Clinical Health Act, 2009 (HITECH)
      • 5.8.3.5 Consumer Privacy Protection Act, 2017
    • 5.8.4 EUROPE
      • 5.8.4.1 General Data Protection Regulation (GDPR), European Union (EU)
      • 5.8.4.2 EU Cybersecurity Act
    • 5.8.5 ASIA PACIFIC
      • 5.8.5.1 China's Cyber Security Law (CSL)
    • 5.8.6 REST OF THE WORLD
      • 5.8.6.1 Protection of Personal Information Act
      • 5.8.6.2 Private cloud computing regulatory framework
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 11 CLINICAL DECISION SUPPORT SYSTEMS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.9.1 THREAT OF NEW ENTRANTS
    • 5.9.2 THREAT OF SUBSTITUTES
    • 5.9.3 BARGAINING POWER OF SUPPLIERS
    • 5.9.4 BARGAINING POWER OF BUYERS
    • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 INDUSTRY TRENDS
    • 5.10.1 GROWING APPLICATIONS OF AI IN CDSS
    • 5.10.2 INCREASING FOCUS ON MOBILE & CLOUD-BASED SOLUTIONS
    • 5.10.3 RISING NEED FOR INTEROPERABILITY & INTEGRATION OF HCIT SOLUTIONS
    • 5.10.4 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS
    • 5.10.5 INCREASING DEMAND FOR VALUE-BASED HEALTHCARE
  • 5.11 BUSINESS MODELS
    • FIGURE 30 BENEFITS OF HYBRID BUSINESS MODELS
  • 5.12 PRICING ANALYSIS
    • 5.12.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
    • FIGURE 31 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
    • 5.12.2 AVERAGE SELLING PRICE TREND, BY REGION
    • TABLE 12 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.13 PATENT ANALYSIS
    • 5.13.1 PATENT PUBLICATION TRENDS FOR CLINICAL DECISION SUPPORT SYSTEMS
    • FIGURE 32 PATENT PUBLICATION TRENDS (JANUARY 2011-JUNE 2023)
    • 5.13.2 INSIGHTS INTO JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 33 CLINICAL DECISION SUPPORT SYSTEMS MARKET: TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR PATENTS (JANUARY 2011-AUGUST 2023)
    • 5.13.3 LIST OF PATENTS/PATENT APPLICATIONS FOR CDSS
  • 5.14 KEY CONFERENCES AND EVENTS
    • TABLE 13 CLINICAL DECISION SUPPORT SYSTEMS: DETAILED LIST OF CONFERENCES AND EVENTS (2023-2024)
  • 5.15 TRADE ANALYSIS
    • 5.15.1 TRADE ANALYSIS FOR CLINICAL DECISION SUPPORT SYSTEM HARDWARE
    • FIGURE 34 IMPORTS OF PRODUCTS UNDER HSN CODE: 901890, BY COUNTRY, 2022 (USD THOUSAND)
    • FIGURE 35 EXPORTS OF PRODUCTS UNDER HSN CODE: 901890, BY COUNTRY, 2022 (USD THOUSAND)
  • 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 36 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
    • TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TYPE (%)
    • 5.16.2 BUYING CRITERIA
    • FIGURE 37 CLINICAL DECISION SUPPORT SYSTEMS: KEY BUYING CRITERIA, BY COMPONENT
    • TABLE 15 BUYING CRITERIA FOR COMPONENTS, BY RANK

6 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT

  • 6.1 INTRODUCTION
    • TABLE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • 6.2 SERVICES
    • 6.2.1 RECURRING REQUIREMENT TO DRIVE MARKET
    • TABLE 17 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 SOFTWARE
    • 6.3.1 USE OF EMR-/EHR-INTEGRATED CDSS TO PROPEL MARKET
    • TABLE 18 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SOFTWARE, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.4 HARDWARE
    • 6.4.1 FREQUENT UPGRADES FOR OPTIMAL USE TO SUPPORT MARKET GROWTH
    • TABLE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR HARDWARE, BY COUNTRY, 2021-2028 (USD MILLION)

7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT

  • 7.1 INTRODUCTION
    • TABLE 20 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 7.2 INTEGRATED CDSS
    • 7.2.1 INTEGRATION WITH EHRS AND RAPID ACCESS TO PATIENT RECORDS TO DRIVE MARKET
    • TABLE 21 INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 STANDALONE CDSS
    • 7.3.1 INTEROPERABILITY ISSUES WITH CPOE AND EHR TO RESTRAIN MARKET
    • TABLE 22 STANDALONE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

8 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE

  • 8.1 INTRODUCTION
    • TABLE 23 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 8.2 THERAPEUTIC CDSS
    • 8.2.1 SEAMLESS INTEGRATION INTO CLINICAL WORKFLOWS TO DRIVE MARKET
    • TABLE 24 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 DIAGNOSTIC CDSS
    • 8.3.1 USE OF ALGORITHMS FOR EFFECTIVE REAL-TIME DIAGNOSIS TO SUPPORT MARKET GROWTH
    • TABLE 25 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL

  • 9.1 INTRODUCTION
    • TABLE 26 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
  • 9.2 KNOWLEDGE-BASED CDSS
    • 9.2.1 DEPLOYS CONDITIONAL LOGIC FOR DECISION-MAKING AND PROBLEM ANALYSIS
    • TABLE 27 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 NON-KNOWLEDGE-BASED CDSS
    • 9.3.1 IMPLEMENTS ML AND AI TO EXPAND USER-DEFINED KNOWLEDGE BASE
    • TABLE 28 NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE

  • 10.1 INTRODUCTION
    • TABLE 29 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
  • 10.2 ON-PREMISE CDSS
    • 10.2.1 LOWER RISK OF DATA BREACH AND ABILITY TO CHOOSE MULTIPLE VENDORS TO DRIVE MARKET
    • TABLE 30 ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.3 CLOUD-BASED CDSS
    • 10.3.1 FLEXIBLE AND SCALABLE FEATURES TO PROPEL MARKET
    • TABLE 31 CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION

  • 11.1 INTRODUCTION
    • TABLE 32 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 11.2 CONVENTIONAL CDSS
    • 11.2.1 ABILITY TO PROVIDE DIAGNOSTIC ASSISTANCE AND PRESCRIPTION DECISION SUPPORT TO DRIVE MARKET
    • TABLE 33 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.3 ADVANCED CDSS
    • 11.3.1 REAL-TIME EVIDENCE AND PROTOCOL VALIDATION BENEFITS TO PROPEL MARKET
    • TABLE 34 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL

  • 12.1 INTRODUCTION
    • TABLE 35 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
  • 12.2 ACTIVE CDSS
    • 12.2.1 ABILITY TO ENABLE OPTIMAL DECISION-MAKING WITH MINIMAL ERRORS TO DRIVE MARKET
    • TABLE 36 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 12.3 PASSIVE CDSS
    • 12.3.1 MINIMAL DISRUPTION TO WORKFLOWS TO SUPPORT MARKET GROWTH
    • TABLE 37 PASSIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING

  • 13.1 INTRODUCTION
    • TABLE 38 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
  • 13.2 INPATIENT SETTINGS
    • 13.2.1 GROWING FOCUS ON IMPROVING HEALTHCARE OPERATIONS IN HOSPITALS TO PROPEL MARKET
    • TABLE 39 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 13.3 AMBULATORY CARE SETTINGS
    • 13.3.1 RISING NEED TO CURB HEALTHCARE COSTS TO DRIVE MARKET
    • TABLE 40 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR AMBULATORY CARE SETTINGS, BY COUNTRY, 2021-2028 (USD MILLION)

14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION

  • 14.1 INTRODUCTION
    • TABLE 41 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 14.2 NORTH AMERICA
    • FIGURE 38 NORTH AMERICA: CDSS MARKET SNAPSHOT
    • TABLE 42 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 43 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 44 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
    • TABLE 45 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 46 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 47 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
    • TABLE 48 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
    • TABLE 49 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 50 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 14.2.1 US
      • 14.2.1.1 Growing focus on value-based care to drive market
    • TABLE 51 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 52 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
    • TABLE 53 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 54 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 55 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
    • TABLE 56 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
    • TABLE 57 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 58 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 14.2.2 CANADA
      • 14.2.2.1 Rising need to curb healthcare costs to propel market
    • TABLE 59 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 60 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
    • TABLE 61 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 62 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 63 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
    • TABLE 64 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
    • TABLE 65 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 66 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 14.2.3 NORTH AMERICA: RECESSION IMPACT
  • 14.3 EUROPE
    • TABLE 67 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 68 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 69 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
    • TABLE 70 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 71 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 72 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
    • TABLE 73 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
    • TABLE 74 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 75 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 14.3.1 GERMANY
      • 14.3.1.1 Favorable government support for adoption of EMRs to propel market
    • TABLE 76 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 77 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
    • TABLE 78 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 79 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 80 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
    • TABLE 81 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
    • TABLE 82 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 83 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 14.3.2 UK
      • 14.3.2.1 Rising establishment of healthcare facilities to fuel market
    • TABLE 84 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 85 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
    • TABLE 86 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 87 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 88 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
    • TABLE 89 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
    • TABLE 90 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 91 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 14.3.3 FRANCE
      • 14.3.3.1 Robust interoperability for EHR systems to drive market
    • TABLE 92 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 93 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
    • TABLE 94 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 95 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 96 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
    • TABLE 97 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
    • TABLE 98 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 99 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 14.3.4 ITALY
      • 14.3.4.1 Rising need for evidence-based CDSS to drive market
    • TABLE 100 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 101 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
    • TABLE 102 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 103 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 104 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
    • TABLE 105 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
    • TABLE 106 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 107 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 14.3.5 SPAIN
      • 14.3.5.1 Growing focus on improving patient outcomes to support market growth
    • TABLE 108 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 109 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
    • TABLE 110 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 111 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 112 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
    • TABLE 113 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
    • TABLE 114 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 115 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 14.3.6 REST OF EUROPE
    • TABLE 116 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 117 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
    • TABLE 118 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 119 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 120 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
    • TABLE 121 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
    • TABLE 122 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 123 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 14.3.7 EUROPE: RECESSION IMPACT
  • 14.4 ASIA PACIFIC
    • FIGURE 39 ASIA PACIFIC: CDSS MARKET SNAPSHOT
    • TABLE 124 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 125 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 126 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
    • TABLE 127 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 128 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 129 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
    • TABLE 130 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
    • TABLE 131 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 132 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 14.4.1 JAPAN
      • 14.4.1.1 Rising need to digitize patient records to propel market
    • TABLE 133 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 134 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
    • TABLE 135 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 136 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 137 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
    • TABLE 138 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
    • TABLE 139 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 140 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 14.4.2 CHINA
      • 14.4.2.1 Established healthcare reforms for EMR solutions to drive market
    • TABLE 141 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 142 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
    • TABLE 143 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 144 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 145 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
    • TABLE 146 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
    • TABLE 147 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 148 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 14.4.3 INDIA
      • 14.4.3.1 Rising adoption of telemedicine to support market growth
    • TABLE 149 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 150 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
    • TABLE 151 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 152 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 153 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
    • TABLE 154 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
    • TABLE 155 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 156 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 14.4.4 REST OF ASIA PACIFIC
    • TABLE 157 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 158 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
    • TABLE 159 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 160 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 161 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
    • TABLE 162 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
    • TABLE 163 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 164 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 14.4.5 ASIA PACIFIC: RECESSION IMPACT
  • 14.5 REST OF THE WORLD
    • TABLE 165 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 166 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 167 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
    • TABLE 168 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 169 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 170 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
    • TABLE 171 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
    • TABLE 172 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 173 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 14.5.1 LATIN AMERICA
      • 14.5.1.1 Developments in healthcare infrastructure to support market growth
    • TABLE 174 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 175 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
    • TABLE 176 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 177 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 178 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
    • TABLE 179 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
    • TABLE 180 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 181 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 14.5.2 MIDDLE EAST & AFRICA
      • 14.5.2.1 Increasing investments in HCIT solutions to propel market
    • TABLE 182 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 183 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021-2028 (USD MILLION)
    • TABLE 184 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 185 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 186 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021-2028 (USD MILLION)
    • TABLE 187 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021-2028 (USD MILLION)
    • TABLE 188 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 189 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 14.5.3 REST OF THE WORLD: RECESSION IMPACT

15 COMPETITIVE LANDSCAPE

  • 15.1 OVERVIEW
  • 15.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • TABLE 190 CLINICAL DECISION SUPPORT SYSTEMS MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
  • 15.3 REVENUE SHARE ANALYSIS OF LEADING MARKET PLAYERS
    • FIGURE 40 REVENUE SHARE ANALYSIS OF KEY PLAYERS
  • 15.4 MARKET SHARE ANALYSIS
    • FIGURE 41 MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
  • 15.5 COMPANY EVALUATION MATRIX
    • 15.5.1 STARS
    • 15.5.2 EMERGING LEADERS
    • 15.5.3 PERVASIVE PLAYERS
    • 15.5.4 PARTICIPANTS
    • 15.5.5 COMPANY FOOTPRINT
    • TABLE 191 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPANY FOOTPRINT OF KEY PLAYERS
    • TABLE 192 CLINICAL DECISION SUPPORT SYSTEMS MARKET: APPLICATION & PRODUCT FOOTPRINT OF KEY PLAYERS
    • TABLE 193 CLINICAL DECISION SUPPORT SYSTEMS MARKET: REGIONAL FOOTPRINT OF KEY PLAYERS
    • FIGURE 42 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPANY EVALUATION MATRIX (2022)
  • 15.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES
    • 15.6.1 PROGRESSIVE COMPANIES
    • 15.6.2 RESPONSIVE COMPANIES
    • 15.6.3 DYNAMIC COMPANIES
    • 15.6.4 STARTING BLOCKS
    • FIGURE 43 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
      • 15.6.4.1 COMPETITIVE BENCHMARKING
    • TABLE 194 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
    • TABLE 195 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES)
  • 15.7 COMPETITIVE SITUATIONS AND TRENDS
    • TABLE 196 CLINICAL DECISION SUPPORT SYSTEMS MARKET: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS (JANUARY 2020-AUGUST 2023)
    • 15.7.1 DEALS
    • TABLE 197 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DEALS (JANUARY 2020-AUGUST 2023)
    • 15.7.2 OTHER DEVELOPMENTS
    • TABLE 198 CLINICAL DECISION SUPPORT SYSTEMS MARKET: OTHER DEVELOPMENTS (JANUARY 2020-AUGUST 2023)

16 COMPANY PROFILES

  • 16.1 KEY PLAYERS

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**

    • 16.1.1 EPIC SYSTEMS CORPORATION
    • TABLE 199 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW
    • 16.1.2 WOLTERS KLUWER N.V.
    • TABLE 200 WOLTERS KLUWER N.V.: BUSINESS OVERVIEW
    • FIGURE 44 WOLTERS KLUWER N.V.: COMPANY SNAPSHOT (2022)
    • 16.1.3 ORACLE
    • TABLE 201 ORACLE: BUSINESS OVERVIEW
    • FIGURE 45 ORACLE: COMPANY SNAPSHOT (2023)
    • 16.1.4 MERATIVE
    • TABLE 202 MERATIVE: BUSINESS OVERVIEW
    • 16.1.5 VERADIGM LLC
    • TABLE 203 VERADIGM LLC: BUSINESS OVERVIEW
    • FIGURE 46 VERADIGM LLC: COMPANY SNAPSHOT (2021)
    • 16.1.6 CHANGE HEALTHCARE (PART OF OPTUM)
    • FIGURE 47 OPTUM.: COMPANY SNAPSHOT (2022)
    • 16.1.7 ATHENAHEALTH
    • TABLE 205 ATHENA HEALTH: BUSINESS OVERVIEW
    • 16.1.8 ELSEVIER (DIVISION OF RELX GROUP)
    • TABLE 206 ELSEVIER: BUSINESS OVERVIEW
    • 16.1.9 ZYNX HEALTH INCORPORATED
    • TABLE 207 ZYNX HEALTH INCORPORATED: BUSINESS OVERVIEW
    • 16.1.10 KONINKLIJKE PHILIPS N.V.
    • TABLE 208 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
    • FIGURE 48 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
    • 16.1.11 MEDICAL INFORMATION TECHNOLOGY, INC.
    • TABLE 209 MEDICAL INFORMATION TECHNOLOGY, INC.: BUSINESS OVERVIEW
    • 16.1.12 NEXTGEN HEALTHCARE, INC.
    • TABLE 210 NEXTGEN HEALTHCARE, INC.: BUSINESS OVERVIEW
    • FIGURE 49 NEXTGEN HEALTHCARE, INC.: COMPANY SNAPSHOT (2022)
    • 16.1.13 CUREMD HEALTHCARE
    • TABLE 211 CUREMD HEALTHCARE: BUSINESS OVERVIEW
    • 16.1.14 SIEMENS HEALTHINEERS
    • TABLE 212 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
    • FIGURE 50 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
    • 16.1.15 EBSCO INFORMATION SERVICES
    • TABLE 213 EBSCO INFORMATION SERVICES: BUSINESS OVERVIEW
    • 16.1.16 GE HEALTHCARE
    • TABLE 214 GE HEALTHCARE: BUSINESS OVERVIEW
    • FIGURE 51 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
    • 16.1.17 ECLINICALWORKS, LLC
    • TABLE 215 ECLINICALWORKS, LLC: BUSINESS OVERVIEW
    • 16.1.18 THE MEDICAL ALGORITHMS COMPANY LIMITED
    • TABLE 216 THE MEDICAL ALGORITHMS COMPANY LIMITED: BUSINESS OVERVIEW
    • 16.1.19 HERA-MI
    • TABLE 217 HERA-MI: BUSINESS OVERVIEW
    • 16.1.20 RAMPMEDICAL
    • TABLE 218 RAMPMEDICAL: BUSINESS OVERVIEW
  • 16.2 OTHER PLAYERS
    • 16.2.1 CARECLOUD, INC.
    • 16.2.2 VISUALDX
    • 16.2.3 STANSON HEALTH (PART OF PREMIER, INC.)
    • 16.2.4 FIRST DATABANK, INC.
    • 16.2.5 STRATA DECISION TECHNOLOGY
    • 16.2.6 ALCIDION
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

17 APPENDIX

  • 17.1 DISCUSSION GUIDE
  • 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 17.3 CUSTOMIZATION OPTIONS
  • 17.4 RELATED REPORTS
  • 17.5 AUTHOR DETAILS